Although the difference between the groups was not significant according to statistical tests, there was a clear trend indicating a difference in RFS between the high- and low-risk groups identified by our signature ( Figure 2B-C ).
← all excerpts
Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature.
1
—
—